In contrast, human vascular cells and glioma-associated myeloid cells respond to STING agonism, and STING activation in intracranial glioblastoma (GBM) murine models drives infiltration of innate immune cells, including macrophages, neutrophils, and NK cells (27). This evidence concerns the gene STING1 and central nervous system cancer.